ID

34247

Description

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg; ODM derived from: https://clinicaltrials.gov/show/NCT01257425

Lien

https://clinicaltrials.gov/show/NCT01257425

Mots-clés

Versions (1)
  1. 15/01/2019 15/01/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

15 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT01257425

Anglais

Eligibility Prostate Cancer NCT01257425

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven prostate cancer, locally advanced or metastatic, or rising psa (prostate-specific antigen) after failed local therapy, and the patient scheduled to receive androgen deprivation therapy
Description

Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | Raised prostate specific antigen | Status post Local Therapy failed | Antiandrogen therapy Scheduled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2]
C0936223
UMLS CUI [3]
C0178415
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C1517925
UMLS CUI [4,3]
C0231175
UMLS CUI [5,1]
C0279492
UMLS CUI [5,2]
C0205539
serum testosterone levels ≥ 125 ng/dl (1.25 ng/ml, 1.25 microg/l, 4.3 nmol/l) measured by any laboratory or on site within the previous 6 months or at study start
Description

Serum testosterone measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0428413
karnofsky performance index > 70
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
expected survival ≥ 9 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior hormonal treatment for prostate cancer including gonadotropin-releasing hormone (gnrh) agonists or antagonists within the last 12 months preceding the study or concomitant treatment with one or more of these substance(s)
Description

Prior Hormone Therapy Prostate carcinoma | GnRH agonists Quantity | GnRH antagonist Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514460
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C2012324
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C1268855
UMLS CUI [3,2]
C1265611
any current use or within 6 months prior to treatment start of medications which are known to affect the metabolism and/or secretion of androgenic hormones: ketoconazole, aminoglutethimide, oestrogens and progesterone
Description

Pharmaceutical Preparations Affecting Metabolism | Pharmaceutical Preparations Affecting Androgen secretion | Ketoconazole | Aminoglutethimide | Estrogens | Progesterone

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0025519
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C3271399
UMLS CUI [3]
C0022625
UMLS CUI [4]
C0002555
UMLS CUI [5]
C0014939
UMLS CUI [6]
C0033308
patient at risk of spinal cord compression or ureter obstruction
Description

At risk Compression of spinal cord | At risk Ureteral obstruction

Type de données

boolean

Alias
UMLS CUI [1,1]
C1444641
UMLS CUI [1,2]
C0037926
UMLS CUI [2,1]
C1444641
UMLS CUI [2,2]
C0041956
prior hypophysectomy or adrenalectomy
Description

Hypophysectomy | Adrenalectomy

Type de données

boolean

Alias
UMLS CUI [1]
C0020632
UMLS CUI [2]
C0001632
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT01257425

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | Raised prostate specific antigen | Status post Local Therapy failed | Antiandrogen therapy Scheduled
Item
histologically or cytologically proven prostate cancer, locally advanced or metastatic, or rising psa (prostate-specific antigen) after failed local therapy, and the patient scheduled to receive androgen deprivation therapy
boolean
C0600139 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C0936223 (UMLS CUI [2])
C0178415 (UMLS CUI [3])
C0231290 (UMLS CUI [4,1])
C1517925 (UMLS CUI [4,2])
C0231175 (UMLS CUI [4,3])
C0279492 (UMLS CUI [5,1])
C0205539 (UMLS CUI [5,2])
Serum testosterone measurement
Item
serum testosterone levels ≥ 125 ng/dl (1.25 ng/ml, 1.25 microg/l, 4.3 nmol/l) measured by any laboratory or on site within the previous 6 months or at study start
boolean
C0428413 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky performance index > 70
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
expected survival ≥ 9 months
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Hormone Therapy Prostate carcinoma | GnRH agonists Quantity | GnRH antagonist Quantity
Item
prior hormonal treatment for prostate cancer including gonadotropin-releasing hormone (gnrh) agonists or antagonists within the last 12 months preceding the study or concomitant treatment with one or more of these substance(s)
boolean
C1514460 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C2012324 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1268855 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Pharmaceutical Preparations Affecting Metabolism | Pharmaceutical Preparations Affecting Androgen secretion | Ketoconazole | Aminoglutethimide | Estrogens | Progesterone
Item
any current use or within 6 months prior to treatment start of medications which are known to affect the metabolism and/or secretion of androgenic hormones: ketoconazole, aminoglutethimide, oestrogens and progesterone
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0025519 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C3271399 (UMLS CUI [2,3])
C0022625 (UMLS CUI [3])
C0002555 (UMLS CUI [4])
C0014939 (UMLS CUI [5])
C0033308 (UMLS CUI [6])
At risk Compression of spinal cord | At risk Ureteral obstruction
Item
patient at risk of spinal cord compression or ureter obstruction
boolean
C1444641 (UMLS CUI [1,1])
C0037926 (UMLS CUI [1,2])
C1444641 (UMLS CUI [2,1])
C0041956 (UMLS CUI [2,2])
Hypophysectomy | Adrenalectomy
Item
prior hypophysectomy or adrenalectomy
boolean
C0020632 (UMLS CUI [1])
C0001632 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial